Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
1
As on 29th Oct 2024 NOVO-B STOCK Price closed @ 768.80 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 770.00 Change Price %
High 781.40 1 Day N/A N/A
Low 768.80 1 Week 0.00 0.00
Close 768.80 1 Month 0.00 0.00
Volume 3303070 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
CO Denmark Most Active Stocks
SAS 0.01 %
CONFRZ 0.01 %
NOVO-B 768.80 %
VWS 128.55 %
DANSKE 197.65 %
BIOPOR 1.96 %
JYSK 485.00 %
ALMB 13.41 %
ASTRLS 1.15 %
BLVIS-A 0.40 -18.37%
 
CO Denmark Top Gainers Stocks
DKIEEU 249.00 15.81%
SYILATKL 237.20 3.40%
CWIGAAKKKL 200.80 3.03%
CWIASKL 243.70 2.65%
JYIKIKL 82.00 2.50%
CWIGAEKL 152.45 2.45%
CWIGAKL 1010.60 2.37%
AOJ-P 88.00 2.33%
CWISAKTKL 177.60 1.92%
NZYM-B 323.50 1.67%
 
CO Denmark Top Losers Stocks
BLVIS-A 0.40 -18.37%
VIPRO 0.88 -4.35%
SEIJHP 103.85 -3.53%
LSIDKA 121.13 -3.29%
SYVAAA 147.59 -2.68%
AUDNTS 5.50 -2.48%
HAINOR 106.06 -2.16%
SYVVUA 100.70 -2.14%
SYIVLVADKKA 162.76 -2.10%
SEIBVP 195.40 -2.03%
 
 
NOVO-B
Daily Charts		 NOVO-B
Intraday Charts		 Whats New @
Bazaartrend		 NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
NOVO-B Forecast October 2024
Share
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
NOVO-B Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
NOVO-B Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service